Skip to main content
Premium Trial:

Request an Annual Quote

TcLand Teams with Radboud Univ. on Biomarkers for RA Drug Response

NEW YORK (GenomeWeb News) – TcLand Expression and Radboud University Nijmegen Medical Center today announced that they will collaborate on looking for biomarkers that predict the effectiveness of drugs for rheumatoid arthritis.

The partners aim to develop a companion diagnostic test for rheumatoid arthritis drugs.

Alessandra Cervino, VP of R&D and biostatistics for Nantes, France-based TcLand Expression, said in a statement that the firm has already developed a test to predict response to rheumatoid arthritis drug infliximab. Now, the firm will work with the researchers at RUNMC to analyze the whole class of anti-TNF drugs.

Further terms of the alliance were not disclosed.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.